Results 341 to 350 of about 965,123 (374)

Remnant-to-LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study. [PDF]

Cardiovasc Diabetol
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Ramos-Bratos MP, López-Gálvez R, Marín F, Roldán V, Lip GYH.   +7 more
europepmc   +1 more source

EFFECT OF MANGOSTEEN’S FRUIT PEEL EXTRACT TOWARD TO TOTAL CHOLESTEROL, LDL, HDL SERUM IN RATS WERE GIVEN BY USED COOKING O

, 2017
Loo Hariyanto Raharjo, Monica Monica
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

What is ‘LDL cholesterol’?

Nature Reviews Cardiology, 2019
LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’.
Michael V. Holmes, Mika Ala-Korpela
openaire   +4 more sources

LDL-cholesterol lowering with obicetrapib

Nature Reviews Cardiology
Gregory B. Lim
openaire   +3 more sources

Beyond lowering LDL cholesterol

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2011
Compelling evidence from randomized controlled studies demonstrated the crucial role of lowering low-density lipoprotein cholesterol (LDL-C) in the prevention of vascular events. However, not all patients with low LDL-C levels show similar reduction in event rates.
Ozgür, Bayturan, Ozan, Utük, E Murat, Tuzcu   +2 more
openaire   +2 more sources

LDL cholesterol impairs therapy

Science Signaling, 2017
A diet high in LDL cholesterol may hinder the therapeutic efficacy of tyrosine kinase inhibitors in cancer patients.
openaire   +2 more sources

Beyond LDL Cholesterol Reduction

Circulation, 1996
Within the past decade, clinical trials of LDL-C reduction have convincingly demonstrated that LDL-C reduction in primary and secondary prevention trials can significantly reduce clinical cardiac events.1 Arteriographic investigations have demonstrated that LDL-C reduction can significantly reduce the rate of arteriographically defined disease ...
openaire   +2 more sources